🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kathleen M. McCarten

Health Insurance Review and Assessment Service

ORCID: 0009-0002-2580-4171
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.208Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013
Top 65%
0.208DataRank
Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Papers

Driven by 13 papers — median percentile 35. Top paper: “Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma”.

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

New England Journal of Medicine(2022)10.1056/nejmoa2206660
N/A
3.7DataRank · unranked
170 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Terzah M. Horton +10 more

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis

Blood(2022)10.1182/blood.2022016098
N/A
0.531DataRank · unranked
14 citations

Frank G. Keller, Kathleen M. McCarten, Sandy Kessel, Steve Cho, Qinglin Pei +8 more

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network

Radiology Artificial Intelligence(2025)10.1148/ryai.240229
N/A
0.402DataRank · unranked
11 citations

Muheon Shin, Changhee Lee, Scott B. Perlman, Zachary Huemann, Amy J. Weisman +8 more

Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.02.020
N/A
0.330DataRank · unranked
7 citations

Kathleen M. McCarten, Qinglin Pei, Sandy Kessel, Adina Alazraki, Joyce Mhlanga +12 more

Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae013
Top 65%
0.208DataRank
Top 65%3 citations

Suzi Birz, Sharon M. Castellino, Tara O. Henderson, John T. Lucas, Qinglin Pei +36 more

Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3876
N/A
0DataRank · unranked
6 citations

Raymond B. Mailhot Vega, Lindsay A. Renfro, Qinglin Pei, Anne-Marie Charpentier, Rahul R. Parikh +15 more

PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1

Pediatric Blood & Cancer(2025)10.1002/pbc.31606
N/A
0DataRank · unranked
3 citations

Yue Wu, Kathleen M. McCarten, Lindsay A. Renfro, Qinglin Pei, Kara M. Kelly +4 more

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients

EJNMMI Physics(2020)10.1186/s40658-020-00346-3
N/A
0DataRank · unranked
45 citations

Ji‐Hyun Kim, Inki Lee, Kathleen M. McCarten, Sandy Kessel, Cindy L. Schwartz +5 more

Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331

Pediatric Blood & Cancer(2025)10.1002/pbc.31856
N/A
0DataRank · unranked
1 citations

Lindsay A. Renfro, Frank G. Keller, David Hodgson, Angela Punnett, Kathleen M. McCarten +6 more

Brentuximab vedotin and association with event-free survival (EFS) in children with newly diagnosed high-risk Hodgkin lymphoma (HL): A report from the Children's Oncology Group phase 3 study AHOD1331 (NCT 02166463).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7504
N/A
0DataRank · unranked
5 citations

Qinglin Pei, Susan K. Parsons, David Hodgson, Kathleen M. McCarten, Angela Punnett +9 more

Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study

British Journal of Haematology(2023)10.1111/bjh.18734
N/A
0DataRank · unranked
16 citations

Ji‐Hyun Kim, Qinglin Pei, Inki Lee, Bradford S. Hoppe, Yue Wu +9 more

PATTERNS OF PRESENTATION AND OUTCOMES IN STAGE IV HODGKIN LYMPHOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP (COG) AHOD1331 TRIAL

Hematological Oncology(2023)10.1002/hon.3163_34
N/A
0DataRank · unranked
1 citations

Kathleen M. McCarten, Qinglin Pei, Sarah A. Milgrom, Joseph L. Belsky, S. Cho +6 more

Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL

Blood Advances(2024)10.1182/bloodadvances.2023012346
N/A
0DataRank · unranked
0 citations

Kathleen M. McCarten, Jamie E. Flerlage, Hollie Lai, Christine Mauz-Koerholz, Karin Dieckmann +7 more